Second wave in the fall. And trouble at tyson foods as china bans its meat imports amid new outbreaks it is monday, june 22nd, you are watching cnbc. Good evening, welcome im Brian Sullivan heres hour you money in the Global Markets are setting up their day. The dow might open up points a mixed session on friday with the dow closing down 208 third down day in a row but what is new, a different story for big tech the nasdaq trying for a 7th straight winning session it is already up nearly 5 this month. Just 35 stoxx of the nasdaq 100 are lower this month and 12 names are up more than 10 the best performer that time, what else . Zoom were all doing the video calls up 35 investors, they continue and its higher again this morning around the world, mostly red arrows in asia overnight europe of course just getting things started karen is in our london newsroom with some of the early action and the early top stories. Karen, good morning. Good morning to you. We have covered a fair amount of t
Session. I said at the time its our obligation to beards why we ran for office when you to be part of it for the good of the nation but we are about to have three straight weeks about one major on the senate relating to the pandemic we face not one, three weeks, not one. Hearings and subcommittees, yes. N activity on the floor of the senate, no. No built brought to the floor in fact an attempt yesterday and the resolution said the United States should be involved in the Global International effort to find a vaccine was projected on the republican side. The reason the senator objected to it its of the Foreign Relations committee see wants to take up the measure in his committing a laternk date i encourage that senator to do it s quickly. Think there is a sense of urgency across america in terms across this emergency theres not a sense of emergency on the republican side of the aisle. Despite the fact the three weeks have not considered one measure on the floor related to this covid viru
The u. S. And china. Here to break down the Market Action is abigail doolittle. The macro news earlier this morning seemed to be about rising trade tensions between the u. S. And china, but then stocks mostly ending in the green. On thisgoing afternoon . Abigail a really sleepy day overall. You have traders not at their desks, checking out just a little early despite the fact that we have macro news. Plus, it is a repeat of last year. At the end of the day, mixed action. But unlike yesterday, we actually had tech closing higher. The nasdaq 100 higher 0. 4 . The chip sector got hit yesterday, rebounded today. Also indicates that traders are brushing off macro concerns. Where we are seeing those concerns play out our for the china adr, the new york thing index, because baidu and alibaba are in there. And the Golden Dragon china etf, down 4 for another day. That is comprised of Chinese Companies in the u. S. , the fear that these companies will be delisted. This is an interesting dynamic
Here as well. Looking at continental europe, spain and france are two countries the hardest hit by the coronavirus along with italy. They are set to ease lockdowns. We have Pedro Sanchez expecting to announce the loosening of measures after the weekly Cabinet Meeting which takes place later today. Later today also, france will be presenting the governments blueprint to the National Assembly on tuesday afternoon, and that should outline how they plan to ease peoples confinement as well. Is the original epicenter of the outbreak on the continent that will soon allow people to leave their homes for the first time in weeks, and that should mean they will be joining other countries including the likes of germany and austria in relaxing of shops to array open up including tattoo studios. In the u. K. , Boris Johnson saying the British Public should keep on obeying lockdown rules to avoid a disasters second wave of this outbreak here as well, coming as the number of recorded deaths from coron
This book. This conversation about antiobesity medications and ozempic has been dominating the news in the us and its something that i cover every single day and its kept me quite busy. Like there is just constant news about this. So im actually i was really curious, you know, when you were writing this book, how did that factor to the writing process . Because i can imagine that, you know, in the in the process of writing this book, there was news and things were changing constantly. And i know that you addressed this the sort of questions that are still lingering out there. But, you know, was was it difficult to sort of render with the constant news flow about these drugs and yeah, i mean, that was a really big and fascinating challenge. Its like documenting a kind of explosion. And 47 of americans want to take these drugs. And were learning more and more about them with every day that comes. And i think it kind of fed into this wider approach that i had all these new developments, b